Skip to main content
. 2020 Sep 18;12(9):887. doi: 10.3390/pharmaceutics12090887

Figure 5.

Figure 5

(A) Correlation of the in vitro cumulative amount of NIA permeated through human skin (4 ≥ n ≥ 3; mean ± SEM) and the in vivo amount of NIA inside the skin at 2 μm after the 60 min application of formulations (n = 8; mean ± SEM). (B) Correlation of the in vitro cumulative amount of NIA permeated through human skin (4 ≥ n ≥ 3; mean ± SEM) and the in vivo concentration of NIA inside the skin (mg/cm3) at 2 μm after the 60 min application of formulations (n = 8; mean ± SEM).